„To learn how not
to age, one must first understand what aging actually is. Yet, even this is not
entirely straightforward. At a recent major scientific congress, participants
were asked to define the term—and ended up providing over thirty different definitions.
For a long time,
the scientific community was divided between two competing theories. Some
argued that the aging and death of living organisms are genetically
programmed—and perhaps even advantageous to a species, as they free up
resources for offspring and accelerate the turnover of generations. Others
maintained that this phenomenon is merely a side effect of life, with no
"self-destruct program" in existence. In this view, an organism
simply sustains constant damage—through the accumulation of mutations,
oxidative stress, and errors in biological molecules—eventually reaching a
point where it can no longer keep up with the necessary repairs.
This debate did
not end with the victory of one theory over the other, but rather with their
synthesis. Most scientists today believe that aging involves both genetically
encoded mechanisms and the gradual accumulation of random damage. Simply put,
how long you live depends not only on your genes but also on your lifestyle.
While the
lifestyle aspect is relatively clear—involving the abandonment of harmful
habits, increased physical activity, and social engagement—the biology of aging
is far more complex. For instance, scientists are currently testing
"geroprotectors"—substances designed to slow aging by targeting
specific biological mechanisms. To date, however, none have proven effective in
slowing the aging process in humans.
Regenerative
medicine offers a somewhat different approach. Although it is a relatively
young field, its core principles—centered on the cellular mechanisms of tissue
repair—were established long ago. Experts in this field link aging to a
diminished capacity of organs and tissues to recover—that is, to
regenerate—following damage. There would be no life without regeneration; when
regeneration ceases, the life of an organism comes to an end.
Specialists in
regenerative medicine draw a clear distinction between two processes: the aging
of an organism and cellular senescence. The decline of an individual cell is
not inherently dangerous—in fact, it is necessary. Most cells have a short
lifespan, and as long as the mechanism for replacing cells that have aged or
lost their normal function remains operational, all is well. The aging of an
organism begins when this mechanism breaks down.
Why does this
happen? In a healthy organism, senescence serves as a protective mechanism—an
alarm signal triggered by damage, effectively saying, "Do something!"
Research from
the 2010s demonstrated that removing cells in the early stages of senescence
actually impairs tissue healing. This signal is evolutionarily essential for
initiating recovery processes.
However, in
advanced senescence, a cell stops dividing and loses the ability to renew its
own components. Most critically, its secretory phenotype changes—meaning the
set of substances it releases to interact with neighboring cells is altered.
Such a cell essentially tells its neighbors, "Age just like I am."
Consequently, the process spreads. Furthermore, senescent cells gradually learn
to evade the immune system, which is otherwise tasked with destroying them.
The
accumulation of these cells shifts the body into a state of chronic
inflammation. A person may remain unaware of this for a long time, until it
manifests as a specific disease. For instance, chronic inflammation within
adipose (fat) tissue can contribute to the development of obesity. Individuals
will, of course, eventually notice a problem, but it may be preceded by a five-
to ten-year period during which dysfunctional cells accumulate. Another
potential consequence is fibrosis—the replacement of healthy tissue with scar
tissue. Fibrosis in vital organs is particularly dangerous and, in severe
cases, can be fatal.
Restoring the
capacity of tissues to renew and regenerate is our primary objective, Our
guiding principle is this: the longer tissues retain their ability to
regenerate properly and clear away aging cells, the longer a person remains
young—perhaps not in terms of chronological age, but biologically.
Our work
focuses on stem cells and mesenchymal stromal cells (MSCs). (Mesenchymal refers
to cells or tissues derived from the mesenchyme—an embryonic connective tissue
that develops into connective tissue, blood vessels, lymphatic tissue, bone,
cartilage, and muscle.)
Stem cells
serve as a kind of "reserve" for the body; they have not yet become
highly specialized.
They possess
two key properties: the ability to divide repeatedly while maintaining their
own population (self-renewal), and the capacity to transform into specialized
cells—such as fat, bone, skin, or muscle cells (differentiation).
While MSCs are
sometimes referred to as stem cells, true stem cells make up less than 1% of
the MSC population. The majority of MSCs act as "efficient managers":
they send essential signals to stem cells and regulate the process of tissue repair.
Both stem
cells and stromal cells reside in specialized niches—complex microenvironments
that allow stem cells to maintain their intrinsic properties and, in the event
of injury, differentiate into the specific cell types required.
As an organism ages, both these niches and the
stem cells they harbor also undergo aging. The signaling systems become
disrupted, and the condition of the cellular components within the niche
deteriorates. Compounding this is chronic inflammation, fueled by the
accumulation of senescent (aging) cells within the tissues.
Niches can be
restored through the introduction of exogenous mesenchymal stromal cells (MSCs)
or their "secretome"—a complex array of molecules that stromal cells
use to orchestrate repair processes. The secretome is multifunctional; among
other components, it contains specific proteins that facilitate the renewal of
niches. Introducing the secretome helps restore the niche’s structure, its
signaling systems, and the function of its supporting cells. Ultimately, this
restores the most critical element: stem cell function, and with it, the
tissue’s regenerative potential.
Furthermore, in
informal discussions at scientific forums, a question is increasingly being
raised: could aging be an evolutionarily developed defense mechanism against
certain threats? If we actively intervene in this process, might we
inadvertently compromise its protective function?
What kind of
threats are we talking about? Primarily, malignant tumors. Aggressively
removing senescent cells could potentially increase the risk of developing
cancer. Another threat involves physical trauma; in older age, injuries heal
much more slowly. Age-related "frailty"—a decline in mobility and
physical capacity—is also considered a potential protective mechanism, even
though it is associated with an increased risk of various diseases. For
instance, if one were to artificially restore muscle strength while the bones
and joints remained unprepared for the increased load, the result could be even
greater harm. Therefore, aging should be viewed from an evolutionary
perspective, and any intervention must be comprehensive—a principle also
embraced by regenerative medicine. The first step involves using personalized
cellular models to identify which specific repair mechanisms have become
impaired in particular tissues, followed by restoring their function. Another
approach is not to destroy aging cells, but rather to alter the signals they
send to neighboring cells. This can be achieved through "senomorphic"
agents or by using the secretome (the set of secreted molecules) derived from
mesenchymal stem cells (MSCs) of young donors. Such an approach might not grant
eternal youth, but it could extend the period during which organs and tissues
retain their functional capacity.
Another
promising avenue is partial cellular reprogramming. This involves introducing
specific genes—known as "Yamanaka factors"—that briefly "roll
back" the settings governing gene activity to a more youthful state. Over
the next decade, it will become clear whether this approach faces significant
limitations—primarily regarding safety—or if it will enable the development of
a new class of therapies designed to "rejuvenate" tissues and the
entire organism.
Finally, we are
likely to gain a deeper understanding of the architecture of aging tissues.
This has proven challenging, as their structure has turned out to be far more
complex than previously assumed. Each tissue contains a multitude of cell
types, with individual cells capable of existing in dozens of distinct states.
However, the rapid advancement of artificial intelligence will accelerate the
analysis of data collected by medical professionals and scientists. I am
hopeful that by the end of the decade, we will have a fundamentally new
understanding of how tissues age—and how to restore their youth, defined as the
ability to function optimally and regenerate.“
Aging is the primary risk factor for cancer. Perhaps by optimizing regenerative processes, it will be possible to reduce the risk of cancer—though many currently fear that these risks might actually increase. Future clinical trials will provide the answer.
Komentarų nėra:
Rašyti komentarą